Trial intelligence / Profile preview

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

NCT05780372Phase 3Active, not recruiting

Sponsor
Sun Yat-sen University
Start
Aug 2023
Primary completion
Apr 2025
Countries
1
01

Overview

Phase 3, randomised, open-label trial in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Regional Recurrence-Free Survival at 3 years. Started Aug 2023; status: active, not recruiting.

02

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT05780372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05780372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call